Shape memory polymer intraocular lenses

US10286105B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10286105-B2
Application numberUS-201615157214-A
CountryUS
Kind codeB2
Filing dateMay 17, 2016
Priority dateMar 7, 2011
Publication dateMay 14, 2019
Grant dateMay 14, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A shape memory polymer (SMP) intraocular lens may have a refractive index above 1.45, a Tg between 10° C. and 60° C., inclusive, de minimiz or an absence of glistening, and substantially 100% transmissivity of light in the visible spectrum. The intraocular lens is then rolled at a temperature above Tg of the SMP material. The intraocular device is radially compressed within a die to a diameter of less than or equal to 1.8 mm while maintaining the temperature above Tg. The compressed intraocular lens device may be inserted through an incision less than 2 mm wide in a cornea or sclera or other anatomical structure. The lens can be inserted into the capsular bag, the ciliary sulcus, or other cavity through the incision. The SMP can substantially achieve refractive index values of greater than or equal to 1.45.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of implanting an intraocular lens device comprising making an incision in a cornea or sclera less than 2 mm wide; and inserting an intraocular lens into the capsular bag through the incision, wherein the intraocular lens device is formed of a shape memory polymer that comprises tert-butyl acrylate and poly(ethylene glycol) dimethacrylate having a molecular weight substantially between 500 and 2000, inclusive, wherein the intraocular lens device is implanted in a compressed and deformed configuration, wherein the intraocular lens device recovers its non-deformed configuration with a recovery rate of between 0.25 seconds and 600 seconds, and wherein the intraocular lens device has a rubbery modulus of 250 kPa to 20,000 kPa. 2. The method of claim 1 , wherein the shape memory polymer further comprises butyl acrylate. 3. The method of claim 1 , wherein the shape memory polymer comprises 50 weight percent tert-butyl acrylate and 22 weight percent poly(ethylene glycol) dimethacrylate 1000, and further comprises 28 weight percent isobutyl acrylate. 4. The method of claim 1 , wherein the shape memory polymer comprises 78 weight percent tert-butyl acrylate and 22 weight percent poly(ethylene glycol) dimethacrylate 1000. 5. The method of claim 1 , wherein the shape memory polymer comprises 65 weight percent tert-butyl acrylate and 22 weight percent poly(ethylene glycol) dimethacrylate 1000, and further comprises 13 weight percent butyl acrylate. 6. The method of claim 1 , wherein the intraocular lens device has a refractive index above 1.45; a Tg between 10° C. and 60° C., inclusive; de minimis or an absence of glistening; and substantially 100% transmissivity of light in the visible spectrum. 7. The method of claim 1 , wherein the intraocular lens device is formed of a shape memory polymer that consists essentially of tert-butyl acrylate, poly(ethylene glycol) dimethacrylate, and optionally an additional monomer selected from the group consisting of isobutyl acrylate and butyl acrylate. 8. A method of implanting an intraocular lens device comprising making an incision in a cornea or sclera less than 2 mm wide; and inserting an intraocular lens into the ciliary sulcus through the incision, wherein the intraocular lens device is formed of a shape memory polymer that comprises tert-butyl acrylate and poly(ethylene glycol) dimethacrylate having a molecular weight substantially between 500 and 2000, inclusive, wherein the intraocular lens device is implanted in a compressed and deformed configuration, wherein the intraocular lens device recovers its non-deformed configuration with a recovery rate of between 0.25 seconds and 600 seconds, and wherein the intraocular lens device has a rubbery modulus of 250 kPa to 20,000 kPa. 9. The method of claim 8 , wherein the shape memory polymer further comprises butyl acrylate. 10. The method of claim 8 , wherein the shape memory polymer comprises 50 weight percent tert-butyl acrylate and 22 weight percent poly(ethylene glycol) dimethacrylate 1000, and further comprises 28 weight percent isobutyl acrylate. 11. The method of claim 8 , wherein the shape memory polymer comprises 78 weight percent tert-butyl acrylate and 22 weight percent poly(ethylene glycol) dimethacrylate 1000. 12. The method of claim 8 , wherein the shape memory polymer comprises 65 weight percent tert-butyl acrylate and 22 weight percent poly(ethylene glycol) dimethacrylate 1000, and further comprises 13 weight percent butyl acrylate. 13. The method of claim 8 , wherein the intraocular lens device has a refractive index above 1.45; a Tg between 10° C. and 60° C., inclusive; de minimis or an absence of glistening; and substantially 100% transmissivity of light in the visible spectrum. 14. The method of claim 8 , wherein the intraocular lens device is formed of a shape memory polymer that consists essentially of tert-butyl acrylate, poly(ethylene glycol) dimethacrylate, and optionally an additional monomer selected from the group consisting of isobutyl acrylate and butyl acrylate. 15. A method of implanting an intraocular lens device comprising making an incision into a cornea less than 2 mm wide to access the anterior chamber; and inserting an intraocular lens into the anterior chamber through the incision, wherein the intraocular lens device is formed of a shape memory polymer that comprises tert-butyl acrylate and poly(ethylene glycol) dimethacrylate having a molecular weight substantially between 500 and 2000, inclusive, wherein the intraocular lens device is implanted in a compressed and deformed configuration, wherein the intraocular lens device recovers its non-deformed configuration with a recovery rate of between 0.25 seconds and 600 seconds, and wherein the intraocular lens device has a rubbery modulus of 250 kPa to 20,000 kPa. 16. The method of claim 15 , wherein the shape memory polymer further comprises butyl acrylate. 17. The method of claim 15 , wherein the shape memory polymer comprises 50 weight percent tert-butyl acrylate and 22 weight percent poly(ethylene glycol) dimethacrylate 1000, and further comprises 28 weight percent isobutyl acrylate. 18. The method of claim 15 , wherein the shape memory polymer comprises 78 weight percent tert-butyl acrylate and 22 weight percent poly(ethylene glycol) dimethacrylate 1000. 19. The method of claim 15 , wherein the shape memory polymer comprises 65 weight percent tert-butyl acrylate and 22 weight percent poly(ethylene glycol) dimethacrylate 1000, and further comprises 13 weight percent butyl acrylate. 20. The method of claim 15 , wherein the intraocular lens device has a refractive index above 1.45; a Tg between 10° C. and 60° C., inclusive; de minimis or an absence of glistening; and substantially 100% transmissivity of light in the visible spectrum. 21. The method of claim 15 , wherein the intraocular lens device is formed of a shape memory polymer that consists essentially of tert-butyl acrylate, poly(ethylene glycol) dimethacrylate, and optionally an additional monomer selected from the group consisting of isobutyl acrylate and butyl acrylate. 22. A method of implanting an intracorneal implant device comprising making an incision into a cornea less than 2 mm wide to create a tunnel in the cornea; and inserting an intracorneal implant device into the anterior chamber through the incision, wherein the intracorneal implant device is formed of a shape memory polymer that comprises tert-butyl acrylate and poly(ethylene glycol) dimethacrylate having a molecular weight substantially between 500 and 2000, inclusive, wherein the intracorneal implant device is implanted in a compressed and deformed configuration, wherein the intracorneal implant device recovers its non-deformed configuration with a recovery rate of between 0.25 seconds and 600 seconds, and wherein the intracorneal implant device has a rubbery modulus of 250 kPa to 20,000 kPa. 23. The method of claim 22 , wherein the shape memory polymer further comprises butyl acrylate. 24. The method of claim 22 , wherein the shape memory polymer comprises 50 weight percent tert-butyl acrylate and 22 weight percent poly(ethylene glycol) dimethacrylate 1000, and further comprises 28 weight percent isobutyl acrylate. 25. The method of claim 22 , wherein the shape memory polymer comprises 78 weight percent tert-butyl acrylate and 22 weight percent poly(ethylene glycol) dimethacr

Assignees

Inventors

Classifications

  • Methods or devices for eye surgery · CPC title

  • Implants for natural eyes · CPC title

  • Having structure for blocking or reducing amount of light transmitted, e.g. glare reduction · CPC title

  • Eye parts, e.g. lenses or corneal implants; Artificial eyes · CPC title

  • A61L27/16Primary

    obtained by reactions only involving carbon-to-carbon unsaturated bonds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10286105B2 cover?
A shape memory polymer (SMP) intraocular lens may have a refractive index above 1.45, a Tg between 10° C. and 60° C., inclusive, de minimiz or an absence of glistening, and substantially 100% transmissivity of light in the visible spectrum. The intraocular lens is then rolled at a temperature above Tg of the SMP material. The intraocular device is radially compressed within a die to a diameter …
Who is the assignee on this patent?
Univ Colorado Regents
What technology area does this patent fall under?
Primary CPC classification A61L27/16. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).